SOLARIS VACCINES

Solaris Vaccines is a biotechnology company that develops therapeutic vaccines for infectious diseases. The Solaris SolaVAX method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria, and parasites. Solaris Vaccines was formed in 2021 to address many of the challenges of creating vaccines in response to emerging threats to global human health.